StockClub

CTMX

CTMXCytomX Therapeutics, Inc.$ --
CytomX Therapeutics, Inc.

CytomX Therapeutics, Inc.

CTMX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
10M USD
YoY -79.9%
Operating Income
-20M USD
YoY -187.0%
Net Income
-18M USD
YoY -177.6%
EPS
-0.1$
YoY -137.0%

Revenue

$10.3M
FY2024 Q2$66.6M
$66.6M
Q2
FY2024 Q3$100M
$100M
Q3
FY2024 Q4$138.1M
$138.1M
Q4
FY2025 Q1$50.9M
$50.9M
Q1
FY2025 Q2$69.6M
$69.6M
Q2
FY2025 Q3$75.5M
$75.5M
Q3
FY2025 Q4$76.2M
$76.2M
Q4
FY2026 Q1$10.3M
$10.3M
Q1
Actual
$-40.7M (-79.9%)

Net Income

$-18.2M
FY2024 Q2$7.3M
$7.3M
Q2
FY2024 Q3$13M
$13M
Q3
FY2024 Q4$31.9M
$31.9M
Q4
FY2025 Q1$23.5M
$23.5M
Q1
FY2025 Q2$23.4M
$23.4M
Q2
FY2025 Q3$9.1M
$9.1M
Q3
FY2025 Q4$-17.4M
$-17.4M
Q4
FY2026 Q1$-18.2M
$-18.2M
Q1
Actual
$-41.8M (-177.6%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$68.4M
Est:$99.9M
FY2020MISS
$68.4M
FY2021MISS
Actual:$37.3M
Est:$69.4M
FY2021MISS
$37.3M
FY2022MISS
Actual:$53.2M
Est:$72M
FY2022MISS
$53.2M
FY2023MISS
Actual:$101.2M
Est:$119.6M
FY2023MISS
$101.2M
FY2024BEAT
Actual:$138.1M
Est:$115.7M
FY2024BEAT
$138.1M
FY2025MISS
Actual:$76.2M
Est:$82.9M
FY2025MISS
$76.2M

Analyst Estimates